Regenerative medicine for degenerative muscle diseases /
General Material Designation
[Book]
First Statement of Responsibility
Martin K. Childers, editor
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xiii, 336 pages) :
Other Physical Details
illustrations (some color).
SERIES
Series Title
Stem cell biology and regenerative medicine,
ISSN of Series
2196-8985
GENERAL NOTES
Text of Note
Includes index
CONTENTS NOTE
Text of Note
Preface; About the Editor; Contents; Chapter 1: Regenerative Medicine Approaches to Degenerative Muscle Diseases; 1.1 Background; 1.1.1 What Is Regenerative Medicine?; 1.1.2 Degenerative Muscle Diseases Are Rare, but Rare Diseases Are Common; 1.2 What Disorders Lead to Chronic Muscle Degeneration?; 1.2.1 Myopathies; 1.2.2 Acquired Myopathies; 1.2.3 Congenital Myopathies; 1.2.4 Muscular Dystrophies; 1.3 Can Human Cells Be Transplanted to Regenerate Damaged Muscles?; 1.3.1 Adult Stem Cells; 1.3.2 Embryonic Stem Cells; 1.3.3 Cellular Reprogramming
Text of Note
1.4 What Is Gene Therapy and When Will It Be Used in Clinical Practice?1.5 Will Gene Replacement Therapy Be Useful for Inherited Muscle Diseases like Muscular Dystrophy?; 1.6 Can Genes Be Repaired?; 1.7 Can Gene Replacement Therapy Rescue Lethal Muscle Disease? Lessons Learned from Dogs; References; Chapter 2: An Overview of rAAV Vector Product Development for Gene Therapy; 2.1 Vector Design and Lead Identification; 2.2 Product Manufacturing; 2.2.1 Scale; 2.2.2 Reagents and Materials; 2.2.3 Process Design and Development; 2.2.4 Upstream Processing; 2.2.5 Downstream Processing